Novara™ for menopause

Menopause diagnosis occurs after 12 uninterrupted months without menstruation. Typical onset happens around age 51, though the range spans 45-55 years. Following hysterectomy, physicians can verify menopausal status through hormone level testing.

Novara™ features bioidentical estradiol (E2) and progesterone (P4) delivered via topical cream. Precise concentrations are customized according to your symptom profile, laboratory findings, and treatment response. Certain preparations may incorporate testosterone or DHEA when clinically indicated.

For most healthy women, yes. Current medical guidelines support HRT as a safe and effective treatment for menopause symptoms, especially when started within 10 years of menopause. Transdermal delivery (like Novara™) has a better safety profile than oral hormones. Our physicians evaluate your individual risk factors before prescribing.

There's no set duration. Many women take HRT for 5-10 years or longer, depending on their symptoms and health profile. The goal is to use the lowest effective dose for the shortest duration needed, but some women benefit from longer treatment. We'll work with you to find what's right.

Systemic HRT is generally not recommended for women with a history of hormone-receptor-positive breast cancer. However, there may be other options available, including low-dose vaginal estrogen for local symptoms. Our physicians can discuss alternatives and coordinate with your oncologist.

Numerous patients report better sleep quality during weeks 1-2. Heat episodes and night sweating generally diminish within 2-4 weeks. Complete therapeutic effects — encompassing emotional stability, enhanced vitality, and cognitive sharpness — typically manifest after 4-8 weeks of regular application.